Table 2.
Number of observed and predicted initiated, completed, and stopped non-COVID-19 trials between March and December 2020.
| Month | Observed Trials (n°) | Forecasted Trials (n°) | 95% Confidence Interval | Difference (%) |
|---|---|---|---|---|
| Initiated Trials | ||||
| March 2020 | 1285 | 2079 | 1704–2454 | −38.2% |
| April 2020 | 765 | 1976 | 1585–2368 | −61.3% |
| May 2020 | 996 | 1974 | 1566–2382 | −49.5% |
| June 2020 | 1530 | 1970 | 1547–2394 | −22.3% |
| July 2020 | 1581 | 1922 | 1484–2361 | −17.7% |
| August 2020 | 1505 | 1913 | 1460–2366 | −21.3% |
| September 2020 | 2198 | 2111 | 1644–2578 | +4.1% |
| October 2020 | 2022 | 2227 | 1747–2708 | −9.2% |
| November 2020 | 1770 | 2042 | 1549–2536 | −13.3% |
| December 2020 | 1874 | 1818 | 1312–2325 | +3.1% |
| Completed Trials | ||||
| March 2020 | 1822 | 1451 | 1153–1749 | +25.6% |
| April 2020 | 1449 | 1462 | 1164–1761 | −0.9% |
| May 2020 | 1289 | 1583 | 1285–1882 | −18.6% |
| June 2020 | 1329 | 1362 | 1064–1661 | −2.4% |
| July 2020 | 1774 | 1498 | 1200–1797 | +18.4% |
| August 2020 | 1427 | 1821 | 1523–2120 | −21.6% |
| September 2020 | 1613 | 1465 | 1167–1764 | −10.1% |
| October 2020 | 1581 | 1700 | 1402–1999 | −7.1% |
| November 2020 | 1736 | 1453 | 1155–1752 | +19.5% |
| December 2020 | 1604 | 1407 | 1109–1706 | +14% |
| Stopped Trials | ||||
| March 2020 | 328 | 264 | 205–323 | +24.2 |
| April 2020 | 309 | 264 | 205–323 | +17.0 |
| May 2020 | 285 | 283 | 224–342 | +0.7 |
| June 2020 | 247 | 234 | 176–293 | +5.6 |
| July 2020 | 364 | 277 | 218–336 | +31.4 |
| August 2020 | 297 | 307 | 248–366 | −3.3 |
| September 2020 | 347 | 236 | 177–295 | +47.0 |
| October 2020 | 358 | 301 | 242–359 | +18.9 |
| November 2020 | 378 | 256 | 198–315 | +47.7 |
| December 2020 | 308 | 224 | 166–283 | +37.5 |